Detalhe da pesquisa
1.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol
; 24(8): 913-924, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414060
2.
Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma.
Haematologica
; 106(1): 173-184, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919085
3.
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.
J Immunol
; 200(8): 2581-2591, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531171
4.
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword.
Int J Mol Sci
; 21(12)2020 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32570952
5.
Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.
Biol Blood Marrow Transplant
; 24(10): 2088-2093, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753162
6.
Immunotherapy: A Novel Era of Promising Treatments for Multiple Myeloma.
Int J Mol Sci
; 19(11)2018 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445802
7.
Natural Killer Cells: Angels and Devils for Immunotherapy.
Int J Mol Sci
; 18(9)2017 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28850071
8.
Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.
Biol Blood Marrow Transplant
; 20(5): 630-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24462744
9.
Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors.
Haematologica
; 99(2): 243-51, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24056818
10.
Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.
Haematologica
; 99(7): 1168-75, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24727813
11.
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment.
Cytotherapy
; 16(1): 84-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24094497
12.
Choosing T-cell sources determines CAR-T cell activity in neuroblastoma.
Front Immunol
; 15: 1375833, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38601159
13.
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.
Sci Transl Med
; 16(734): eadg7962, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354229
14.
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.
Clin Cancer Res
; 30(10): 2085-2096, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466644
15.
A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments.
Cancers (Basel)
; 14(15)2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954459
16.
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome.
Sci Adv
; 8(39): eabo0514, 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179026
17.
Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors.
Haematologica
; 96(1): 102-9, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20851866
18.
Inflammaging, an Imbalanced Immune Response That Needs to Be Restored for Cancer Prevention and Treatment in the Elderly.
Cells
; 10(10)2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34685542
19.
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner.
Front Immunol
; 12: 717850, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34447383
20.
IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation.
Cancers (Basel)
; 13(14)2021 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298748